U.S. Contraceptive Market
完整報告名稱與涵蓋範圍
U.S. Contraceptive Market Size, Share & Trends Analysis Report, By Product Type (Oral Contraceptives, Long-Acting Reversible Contraceptives (IUDs and Implants), Injectable, Patch and Vaginal Ring Contraceptives, Emergency Contraception, Barrier and Non-Hormonal Products), By Availability (Prescription Products, Over-the-Counter Products), By Distribution Channel (Retail Pharmacies and Mass Merchandisers, Clinics and Hospitals, Online and Telehealth Pharmacies), By Age Group, and Segment Forecasts, 2026-2035
報告摘要
The U.S. contraceptive market covers prescription and over-the-counter contraceptive products sold in the United States, including oral contraceptives, long-acting reversible methods such as intrauterine devices and implants, injectables, patches and rings, emergency contraception and barrier and non-hormonal products, across retail, clinic and telehealth channels. Fertility treatments, sterilization procedures and markets outside the United States are excluded.
The market is being reshaped by the first over-the-counter daily oral contraceptive, by telehealth platforms that prescribe and ship contraceptives directly, by pharmacist prescribing authority in a growing number of states and by continued growth of long-acting reversible methods that offer multi-year protection. Policy variation across states following changes to abortion access has raised demand for reliable contraception and emergency contraception in some regions while complicating access in others, and coverage requirements under federal law continue to shape out-of-pocket dynamics. Generic erosion of older oral contraceptives, extended-duration IUD labelling and non-hormonal innovation define competitive activity.
Demand is distributed nationally, with the largest volumes in populous states and growing online share among younger users. Competition involves multinational women's health franchises, generic manufacturers, consumer health companies and digital-first telehealth brands.
The InsightAce study provides US$ revenue forecasts for every product type, availability, distribution channel and age group segment over 2026-2035, plus segment trend analysis, competitive landscape mapping and profiles of leading participants.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. U.S. Contraceptive Market Snapshot
Chapter 4. U.S. Contraceptive Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Product Type Estimates & Trend Analysis
5.1. Product Type & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Product Type:
5.2.1. Oral Contraceptives
5.2.2. Long-Acting Reversible Contraceptives (IUDs and Implants)
5.2.3. Injectable, Patch and Vaginal Ring Contraceptives
5.2.4. Emergency Contraception
5.2.5. Barrier and Non-Hormonal Products
Chapter 6. Market Segmentation 2: By Availability Estimates & Trend Analysis
6.1. Availability & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Availability:
6.2.1. Prescription Products
6.2.2. Over-the-Counter Products
Chapter 7. Market Segmentation 3: By Distribution Channel Estimates & Trend Analysis
7.1. Distribution Channel & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Distribution Channel:
7.2.1. Retail Pharmacies and Mass Merchandisers
7.2.2. Clinics and Hospitals
7.2.3. Online and Telehealth Pharmacies
Chapter 8. Market Segmentation 4: By Age Group Estimates & Trend Analysis
8.1. Age Group & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Age Group:
8.2.1. Adolescents and Young Adults (15-24)
8.2.2. Adults (25-44)
8.2.3. Perimenopausal Women (45 and Above)
Chapter 9. U.S. Contraceptive Market: Country Outlook & Operating Environment
9.1. Regulatory & Policy Framework
9.2. Pricing, Reimbursement & Procurement Environment
9.3. Demand Outlook & Adoption Trends, 2026-2035
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. Bayer AG
11.2. Organon & Co.
11.3. Pfizer Inc.
11.4. CooperSurgical, Inc.
11.5. Perrigo Company plc
11.6. Foundation Consumer Healthcare
11.7. Sebela Women's Health Inc.
11.8. Agile Therapeutics, Inc.
11.9. Evofem Biosciences, Inc.
11.10. Mayne Pharma Group Limited
11.11. Teva Pharmaceutical Industries Ltd.
11.12. Lupin Ltd.
11.13. Church & Dwight Co., Inc.
11.14. Reckitt Benckiser Group plc
11.15. Nurx (Thirty Madison)
圖表清單 List of Tables & Figures
Table 1. U.S. Contraceptive Market Revenue Forecast by Product Type, 2026-2035 (US$ Mn)
Figure 1. U.S. Contraceptive Market Segmentation and Scope Overview
Table 2. U.S. Contraceptive Market Revenue Forecast by Availability, 2026-2035 (US$ Mn)
Figure 2. U.S. Contraceptive Market Share by Product Type, 2026 & 2035
Table 3. U.S. Contraceptive Market Revenue Forecast by Distribution Channel, 2026-2035 (US$ Mn)
Figure 3. U.S. Contraceptive Use by Method and Age Group, 2026-2035
Table 4. U.S. Contraceptive Market Revenue Forecast by Age Group, 2026-2035 (US$ Mn)
Figure 4. Over-the-Counter, Pharmacist-Prescribed and Telehealth Access Channels for Contraception
Table 5. U.S. Contraceptive Market Revenue and Volume Snapshot, 2026-2035
Figure 5. U.S. Contraceptive Market Growth Opportunity Analysis by Segment, 2026-2035
Table 6. Strategic Developments of Leading U.S. Contraceptive Market Participants, 2023-2026
Figure 6. Competitive Positioning of Key U.S. Contraceptive Market Participants
Figure 7. Porter's Five Forces Analysis of the U.S. Contraceptive Market
Figure 8. State-Level Policy Variation and Its Effect on Contraceptive Demand
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們